BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 34268906)

  • 1. Squalene epoxidase promotes colorectal cancer cell proliferation through accumulating calcitriol and activating CYP24A1-mediated MAPK signaling.
    He L; Li H; Pan C; Hua Y; Peng J; Zhou Z; Zhao Y; Lin M
    Cancer Commun (Lond); 2021 Aug; 41(8):726-746. PubMed ID: 34268906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Squalene epoxidase drives cancer cell proliferation and promotes gut dysbiosis to accelerate colorectal carcinogenesis.
    Li C; Wang Y; Liu D; Wong CC; Coker OO; Zhang X; Liu C; Zhou Y; Liu Y; Kang W; To KF; Sung JJ; Yu J
    Gut; 2022 Nov; 71(11):2253-2265. PubMed ID: 35232776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Squalene epoxidase promotes the chemoresistance of colorectal cancer via (S)-2,3-epoxysqualene-activated NF-κB.
    Liu Q; Zhang Y; Li H; Gao H; Zhou Y; Luo D; Shan Z; Yang Y; Weng J; Li Q; Yang W; Li X
    Cell Commun Signal; 2024 May; 22(1):278. PubMed ID: 38762737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of Squalene Epoxidase by Cholesterol Accumulation Accelerates Colorectal Cancer Progression and Metastasis.
    Jun SY; Brown AJ; Chua NK; Yoon JY; Lee JJ; Yang JO; Jang I; Jeon SJ; Choi TI; Kim CH; Kim NS
    Gastroenterology; 2021 Mar; 160(4):1194-1207.e28. PubMed ID: 32946903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Squalene epoxidase/SQLE is a candidate target for treatment of colorectal cancers with
    Du Y; Rokavec M; Hermeking H
    Int J Biol Sci; 2023; 19(13):4103-4122. PubMed ID: 37705742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Squalene epoxidase promotes hepatocellular carcinoma development by activating STRAP transcription and TGF-β/SMAD signalling.
    Zhang Z; Wu W; Jiao H; Chen Y; Ji X; Cao J; Yin F; Yin W
    Br J Pharmacol; 2023 Jun; 180(12):1562-1581. PubMed ID: 36581319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of squalene epoxidase linking with PI3K/AKT signaling pathway suppresses endometrial cancer.
    Ma L; Huang W; Liang X; Bai G; Wang X; Jiang H; Xin Y; Hu L; Chen X; Liu C
    Cancer Sci; 2023 Sep; 114(9):3595-3607. PubMed ID: 37438885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Squalene epoxidase-induced cholesteryl ester accumulation promotes nasopharyngeal carcinoma development by activating PI3K/AKT signaling.
    Li L; Zhang Q; Wang X; Li Y; Xie H; Chen X
    Cancer Sci; 2020 Jul; 111(7):2275-2283. PubMed ID: 32314495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Squalene epoxidase promotes the proliferation and metastasis of lung squamous cell carcinoma cells though extracellular signal-regulated kinase signaling.
    Ge H; Zhao Y; Shi X; Tan Z; Chi X; He M; Jiang G; Ji L; Li H
    Thorac Cancer; 2019 Mar; 10(3):428-436. PubMed ID: 30734525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Squalene epoxidase (SQLE) promotes the growth and migration of the hepatocellular carcinoma cells.
    Sui Z; Zhou J; Cheng Z; Lu P
    Tumour Biol; 2015 Aug; 36(8):6173-9. PubMed ID: 25787749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SQLE promotes pancreatic cancer growth by attenuating ER stress and activating lipid rafts-regulated Src/PI3K/Akt signaling pathway.
    Xu R; Song J; Ruze R; Chen Y; Yin X; Wang C; Zhao Y
    Cell Death Dis; 2023 Aug; 14(8):497. PubMed ID: 37542052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squalene epoxidase facilitates cervical cancer progression by modulating tumor protein p53 signaling pathway.
    Guo M; Qiao Y; Lu Y; Zhu L; Zheng L
    J Obstet Gynaecol Res; 2023 May; 49(5):1383-1392. PubMed ID: 36843235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target.
    Liu D; Wong CC; Fu L; Chen H; Zhao L; Li C; Zhou Y; Zhang Y; Xu W; Yang Y; Wu B; Cheng G; Lai PB; Wong N; Sung JJY; Yu J
    Sci Transl Med; 2018 Apr; 10(437):. PubMed ID: 29669855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related cholesterol and colorectal cancer progression: Validating squalene epoxidase for high-risk cases.
    Jun SY; Yoon HR; Yoon JY; Lee JJ; Kim JY; Kim JM; Kim NS
    Aging Cell; 2024 Mar; ():e14152. PubMed ID: 38517197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 and MYC-regulated squalene epoxidase as Achilles heel in colorectal cancer.
    Fischer M
    Int J Biol Sci; 2023; 19(15):4831-4832. PubMed ID: 37781510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Squalene Epoxidase Interrupts Homologous Recombination via the ER Stress Response and Promotes Radiotherapy Efficacy.
    Hong Z; Liu T; Wan L; Fa P; Kumar P; Cao Y; Prasad CB; Qiu Z; Liu J; Wang H; Li Z; Wang QE; Guo P; Guo D; Yilmaz AS; Lu L; Papandreou I; Jacob NK; Yan C; Zhang X; She QB; Ma Z; Zhang J
    Cancer Res; 2022 Apr; 82(7):1298-1312. PubMed ID: 35045984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Squalene Epoxidase Induces Nonalcoholic Steatohepatitis Via Binding to Carbonic Anhydrase III and is a Therapeutic Target.
    Liu D; Wong CC; Zhou Y; Li C; Chen H; Ji F; Go MYY; Wang F; Su H; Wei H; Cai Z; Wong N; Wong VWS; Yu J
    Gastroenterology; 2021 Jun; 160(7):2467-2482.e3. PubMed ID: 33647280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Squalene synthase predicts poor prognosis in stage I-III colon adenocarcinoma and synergizes squalene epoxidase to promote tumor progression.
    Jiang H; Tang E; Chen Y; Liu H; Zhao Y; Lin M; He L
    Cancer Sci; 2022 Mar; 113(3):971-985. PubMed ID: 34939274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of SQLE Contributes to Poor Survival in Head and Neck Squamous Cell Carcinoma.
    Li J; Yang T; Wang Q; Li Y; Wu H; Zhang M; Qi H; Zhang H; Li J
    Int J Biol Sci; 2022; 18(9):3576-3591. PubMed ID: 35813482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying squalene epoxidase as a metabolic vulnerability in high-risk osteosarcoma using an artificial intelligence-derived prognostic index.
    Wang Y; Ma X; Xu E; Huang Z; Yang C; Zhu K; Dong Y; Zhang C
    Clin Transl Med; 2024 Feb; 14(2):e1586. PubMed ID: 38372422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.